Home › Durham's acne drug developer raises $50M, partly from Jim Goodnight
 

Keywords :   


Durham's acne drug developer raises $50M, partly from Jim Goodnight

2015-03-31 05:53:05| Biotech - Topix.net

The financing comes from a group that includes new investor Malin Corporation in a fund backed partly by billionaire SAS founder Jim Goodnight and brings new board members G. Kelly Martin , former CEO of Elan Corp. , and Sean Murphy , former head of M&A and business development for Abbott Laboratories , to help oversee the investment. "We believe the promise of Novan's pipeline and our advancement toward commercialization enabled us to attract strong participation in this round, leading us to close at twice the original target of $25 million," says Neal Hunter , Novan's founding investor and chairman.

Tags: drug jim developer partly

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
02.11Subtropical Storm Patty Graphics
02.11Tropical Storm Lane Graphics
02.11Tropical Storm Lane Wind Speed Probabilities Number 5
02.11Tropical Storm Lane Forecast Advisory Number 5
02.11Tropical Storm Lane Public Advisory Number 5
02.11Summary for Tropical Storm Lane (EP3/EP132024)
02.11Subtropical Storm Patty Forecast Discussion Number 3
02.11Subtropical Storm Patty Wind Speed Probabilities Number 3
More »